| |
|
|
|
|
|
|
|||
|
1 Division of Hematology, Department of Medicine, Montefiore Hospital and
Medical Center, Bronx, N.Y.; The Laboratory of Experimental Hematology, Department of
Biology, Graduate School of Arts and Science, New York University, New York, N. Y.;
Section of Hematology, Morrisania-Montefiore Affiliation, Bronx, N. Y.; and the Department
of Medicine (Hematology), Mount Sinai School of Medicine of the City University of New
York, New York, N. Y.
A 32-yr-old black female with pure red
cell aplasia and thymoma showed complete hematologic remission after thymectomy. Bioassay of preoperative serum
and urine in exhypoxic polycythemic
mice revealed the presence of significant
levels of erythropoiesis-stimulating factor
(ESF or erythropoietin). Antierythropoietin completely neutralized the erythropoietic effect of these samples. Utilizing
both normal and exhypoxic polycythemic
mice, the preoperative serum and urine
were also found to contain a potent inhibitor of erythropoiesis. However, no
such activity was demonstrated in saline
extracts of the tumor tissue. The inhibitor was present in the serum IgG
fraction. Serum to which excess ESF had
been added, after prior neutralization of
endogenous ESF with anti-ESF, failed
to stimulate erythropoiesis in the polycythemic mouse.
This article has been cited by other articles:
| ||||||||||
| Copyright © 1971 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||